Biofrontera AG American Depositary Shares
BFRA
BFRA was delisted on the 4th of March, 2022.
0 hedge funds and large institutions have $0 invested in Biofrontera AG American Depositary Shares in 2024 Q2 according to their latest regulatory filings, with funds opening new positions, increasing their positions, reducing their positions, and 1 closing their positions.
100% less funds holding
Funds holding: 1 → 0 (-1)
100% less capital invested
Capital invested by funds: $714 → $0 (-$714)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RhumbLine Advisers
Boston,
Massachusetts
|
-$714 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
RhumbLine Advisers
Boston,
Massachusetts
| – | -$714 | -288 | Closed |
|
BFRA Hedge Fund Activity: Q2 2024 in Review
0 of the 6,925 institutional investors tracked by Wall St. Rank reported a position in Biofrontera AG American Depositary Shares (BFRA) for Q2 2024, worth a combined $0 — down 100% from $714 a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of BFRA and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.
The largest seller was RhumbLine Advisers, exiting entirely with an estimated $714 sold.
- 0 institutional investors held Biofrontera AG American Depositary Shares (BFRA) as of Q2 2024, down from 1 in Q1 2024.
- Funds reported $0 of Biofrontera AG American Depositary Shares stock for Q2 2024, down 100% quarter-over-quarter.
- 0 funds opened new Biofrontera AG American Depositary Shares positions in Q2 2024 and 1 closed out, a net change of -1 holder.
- The largest Biofrontera AG American Depositary Shares seller in Q2 2024 was RhumbLine Advisers, an estimated $714 sold.
Based on aggregated 13F filings for Q2 2024.